UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000026516
Receipt number R000030449
Scientific Title Early and Short-term Use of PCSK9-Inhibitors on Coronary Plaque Stability in Acute Coronary Syndrome
Date of disclosure of the study information 2017/03/13
Last modified on 2023/12/05 15:41:20

No. Disposal Last modified on Item of update
1 Insert 2017/03/13 00:31:04
2 Update 2017/03/20 19:12:56 Key inclusion criteria
Key inclusion criteria
3 Update 2018/09/16 16:16:01 Recruitment status
Last follow-up date
Date of closure to data entry
4 Update 2019/03/15 10:09:52 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
5 Update 2019/03/15 10:29:58 Date of IRB
Last follow-up date
Date of closure to data entry
6 Update 2022/06/30 16:55:24 Primary outcomes
Primary outcomes
7 Update 2023/06/24 11:35:57 Number of participants that the trial has enrolled
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
8 Update 2023/07/11 13:14:20 Trial characteristics_1
Trial characteristics_2
Developmental phase
Key secondary outcomes
Key secondary outcomes
9 Update 2023/07/11 13:16:09 Interventions/Control_1
Interventions/Control_1
10 Update 2023/07/11 13:19:21 Department
Personal name
Personal name
Organization
Organization
Division
Nationality of Funding Organization
Nationality of Funding Organization
11 Update 2023/07/11 16:01:40 URL releasing protocol
URL related to results and publications
Plan to share IPD
Plan to share IPD
12 Update 2023/07/15 15:08:17 Recruitment status
Date trial data considered complete
Date analysis concluded
13 Update 2023/12/05 15:22:15 Results
Results
Outcome measures
Outcome measures
14 Update 2023/12/05 15:33:47 Key secondary outcomes
15 Update 2023/12/05 15:41:20 Public title